The CAT-RA Study for Rheumatoid Arthritis and Heart Disease Risk
This study, called CAT-RA, is looking at how to better identify people with rheumatoid arthritis (RA) who are at higher risk for heart disease. People with RA have a greater chance of having a heart attack. Researchers are testing if measuring high sensitivity cardiac troponin (a blood test for heart damage) and coronary artery calcium (a measure of plaque in heart arteries) can help doctors find these risks earlier. This could lead to starting preventative treatments sooner. You might be able to join if you have RA, are between 35 and 79 years old, and have at least one heart disease risk factor like prediabetes or high blood pressure. The study is looking for 120 participants.
- Study design
- This is an observational study, meaning participants are observed without receiving a specific treatment from the study. It plans to enroll 120 participants.
- What's involved
- Not specified in the trial record.
- Compensation
- Not stated in the trial record.
- Follow-up
- The primary endpoint, coronary artery calcium score, is measured at baseline, but no further follow-up is specified.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
The Coronary Artery Calcium and Troponins in Rheumatoid Arthritis (CAT-RA) Study
At a glance
Conditions
Where it's being run
3 sites across 1 statesWho to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- coronary artery calcium scoreCross-sectional, at baseline
Quantified coronary artery calcium score